Sino Biopharmaceutical Ltd's Fiscal Year is From January To December - All Figures are in HKD, Billions.
The item "Other-Stockholder-Equity" stands at 21.74 Billion Hong Kong Dollars as of 06/30/2025, the highest value since 03/31/2024.
As of the end of Sino Biopharmaceutical Ltd's second quarter, the item "Other Stockholder Equity" stands at 21.74 Billion HKD. This represents no change compared to it's value at the end of it's first quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 3.51 Billion Hong Kong Dollars compared to the value the year prior.
The 1 year change is 3.51 Billion Hong Kong Dollars.
The 3 year change is 2.10 Billion Hong Kong Dollars.
The 5 year change is -0.741 Billion Hong Kong Dollars.
The 10 year change is 19.10 Billion Hong Kong Dollars.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Other Stockholder Equity | 905,699,262,464.00 |
![]() | Johnson & Johnson - Other Stockholder Equity | 486,508,953,600.00 |
![]() | AbbVie Inc - Other Stockholder Equity | 399,570,305,024.00 |
![]() | Roche Holding AG - Other Stockholder Equity | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Other Stockholder Equity | 280,205,508,085.11 |